跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BORTRACZO bortezomib 2.5 mg/1 mL solution for injection
Approved
STANDARD
BORTRACZO bortezomib 2.5 mg/1 mL solution for injection
Glenmark Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
74075143ec14cf8d
Company
Glenmark Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
74075143ec14cf8d
Product Name
BORTRACZO bortezomib 2.5 mg/1 mL solution for injection
Artg Id
444811
Artg Name
BORTRACZO bortezomib 2.5 mg/1 mL solution for injection vial
Sponsor
Glenmark Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/glenmark-pharmaceuticals-australia-pty-limited
Artg Date
2025-05-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
74075143ec14cf8d
Type
Standard
Back to TGA Approvals
BORTRACZO bortezomib 2.5 mg/1 mL solution for injection - TGA Drug Approval Details
